A pediatrician weighs in on the White House's vaccine plan for young kids
NPR's Sarah McCammon talks with pediatrician Dr. Rhea Boyd about the White House's announced plans for rolling out a vaccine for children ages 5 to 11.
Medical Treatments
Expert helps untangle vaccine misinformation that has followed Colin Powell's death
NPR's Sarah McCammon talks with Dr. Hyung Chun, professor of cardiology at Yale and senior author of a study in COVID breakthrough cases, on vaccine misinformation following the death of Colin Powell.
EMTs and paramedics in Maine are quitting rather than get the COVID vaccinate
In Maine, EMTs and paramedics are part of the COVID vaccine mandate for health care workers. The deadline is looming, and some ambulance crews say coworkers have quit rather than get vaccinated.
Some Chicago cops won't share vaccine status, even if it means they lose police power
Chicago is requiring its workers to be vaccinated or undergo twice-weekly testing on their own time and dime. The head of the police union is urging cops not to share their vaccination info.
Scientists in South Africa are working to reverse engineer the Moderna COVID vaccine
A consortium in South Africa wants to teach manufacturers in poor countries to make Moderna's COVID vaccine. But Moderna won't share its process. So the scientists are trying to reverse engineer it.
Patients say telehealth is OK, but most prefer to see their doctor in person
An NPR poll finds that while a large majority of people using telehealth during the pandemic were satisfied, nearly two-thirds prefer in-person visits. That may foretell telehealth's future.
We help answer your questions about COVID-19 vaccine boosters
NPR's Michel Martin speaks with Norman Baylor, former director of the FDA's Office of Vaccines Research and Review, about the differences in booster recommendations for the COVID-19 vaccines.
Kentucky's backroad churches may be key to saving hospitals overwhelmed by COVID
Public health workers are going church to church and house to house in the state's secluded valleys to dispel COVID myths, ease isolation, bring aid, and convince wary residents to get vaccinated.
FDA advisers all voted to recommend the authorization of a Johnson & Johnson booster
The FDA's advisory committee met to debate the best course ahead for improving immunity against the delta variant for people who received the Johnson & Johnson vaccine.
Experts recommend that FDA should authorize Moderna COVID vaccine booster
The recommendation applies to people 65 years and older, those 18 to 64 who are at high risk of severe COVID and those whose work or institutional exposure puts them at high COVID risk.